BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6176450)

  • 1. Immunologic monitoring of cervical carcinoma.
    Almerigogna F; Borri P; Buzzoni P; Locatelli F; Savino L
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):164-7. PubMed ID: 6176450
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor markers in the ovarian carcinoma.
    Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
    Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of the presence of tumor associated antigens in the clinical evolution of the ovarian carcinoma: analysis of 13 cases in stage III and IV.
    Sacco F; Benedetti Panici P; Margariti PA; Di Roberto P; Maiorca A; Muscatello P; Villani L; Iacobelli S
    Eur J Gynaecol Oncol; 1980 Dec; 1(3):136-9. PubMed ID: 6176449
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncofoetal antigens in cancer of the cervix and ovary.
    Cauchi MN; Koh SH; Lim D; Hay DL
    Br J Cancer; 1981 Sep; 44(3):403-9. PubMed ID: 6169360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated antigens in polyps and carcinoma of the human large bowel.
    Skinner JM; Whitehead R
    Cancer; 1981 Mar; 47(6):1241-5. PubMed ID: 6164469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of tumor markers in patients with squamous cell carcinoma of the uterine cervix.
    Fritsche HA; Freedman RS; Liu F; Acomb LD; Collinsworth WL
    Gynecol Oncol; 1982 Oct; 14(2):230-5. PubMed ID: 6182055
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunocytochemical localization of carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (HCG) in cervical neoplasia.
    Bychkov V; Rothman M; Bardawil WA
    Am J Clin Pathol; 1983 Apr; 79(4):414-20. PubMed ID: 6188359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
    Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
    Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers: how useful are they?
    McIntire KR
    Hosp Pract (Off Ed); 1984 Dec; 19(12):55-68. PubMed ID: 6209292
    [No Abstract]   [Full Text] [Related]  

  • 14. [Course studies by means of tumor markers].
    Quentmeier A
    Aktuelle Probl Chir Orthop; 1980; 74():43-6. PubMed ID: 6156606
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological markers in human lung carcinoma: an immunopathological study of six antigens.
    Harach HR; Skinner M; Gibbs AR
    Thorax; 1983 Dec; 38(12):937-41. PubMed ID: 6198740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
    Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
    Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor markers in testis tumors.
    Kansu E
    Turk J Pediatr; 1984; 26(1-4):277-83. PubMed ID: 6085661
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic significance and clinical application of tumour-associated antigens in man with special reference to the carcinoembryonic antigen.
    Wagener C; Breuer H
    J Clin Chem Clin Biochem; 1977 Oct; 15(10):529-43. PubMed ID: 72783
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and management of cancer using tumor markers].
    Torigoe T; Kato H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1672-6. PubMed ID: 6194233
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncofetal and oncoplacental antigens as tumor markers.
    Yamauchi S; Miyake H
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):95-109. PubMed ID: 2463397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.